Ohio Administrative Code Search

...horized user, an authorized nuclear pharmacist, ophthalmic physicist, or an authorized medical physicist; (F) The provisions of paragraph (B)(5) of rule 3701:1-58-09 of the Administrative Code regarding additions to or changes in the areas of use identified in the application or on the license where radioactive material is used in accordance with either rule 3701:1-58-32 or 3701:1-58-34 of th...

... an authorized user, authorized nuclear pharmacist, or authorized medical physicist; and (3) Radiation protection program changes that do not require a license amendment and are permitted under rule 3701:1-58-13 of the Administrative Code. (B) A licensee's management shall appoint a radiation safety officer, who agrees, in writing, to be responsible for implementing the radiation protection program. The licensee, ...

...authorized user, authorized nuclear pharmacist, or authorized medical physicist; and (3) Radiation protection program changes that do not require a license amendment and are permitted under rule 3701:1-58-13 of the Administrative Code. (B) A licensee's management shall appoint a radiation safety officer, who agrees, in writing, to be responsible for implementing the radiation protection program....

...he supervision of an authorized nuclear pharmacist or physician who is an authorized user, as allowed by paragraph (B)(2) of rule 3701:1-58-06 of the Administrative Code shall: (1) In addition to the requirements in rule 3701:1-38-10 of the Administrative Code, instruct the supervised individual in the preparation of radioactive material for medical use, as appropriate to that individual's involvement with radioacti...

...edical physicist, or authorized nuclear pharmacist identified on a United States nuclear regulatory commission or an agreement state license, a permit issued by a United States nuclear regulatory commission master material licensee, a permit issued by a United States nuclear regulatory commission or an agreement state licensee of broad scope, or a permit issued by a United States nuclear regulator...

... shall require the authorized nuclear pharmacist to be a pharmacist who: (A) Is certified by a specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement state. The names of board certifications which have been recognized by the director, United States nuclear regulatory commission, or an agreement state will be post...

...authorized medical physicist, a nuclear pharmacist or an authorized nuclear pharmacist on a United States nuclear regulatory commission or agreement state license or a permit issued by a United States nuclear regulatory commission or agreement state broad scope licensee or master material license permit or by a master material license permittee of broad scope on or before January 14, 2019 need not...

...prepared by: (1) An authorized nuclear pharmacist; or (2) A physician who is an authorized user and who meets the requirements specified in rule 3701:1-58-36, or rule 3701:1-58-40 and paragraph (C)(1)(b)(vii) of rule 3701:1-58-36 of the Administrative Code; or (3) An individual under the supervision, as specified in rule 3701:1-58-14 of the Administrative Code, of the authorized nuclear pharmacist in paragraph (B)...

...prepared by: (1) An authorized nuclear pharmacist; (2) A physician who is an authorized user and who meets the requirements specified in rule 3701:1-58-36 or 3701:1-58-40 and paragraph (C)(1)(b)(vii) of rule 3701:1-58-36 of the Administrative Code; or (3) An individual under the supervision, as specified in rule 3701:1-58-14 of the Administrative Code, of the authorized nuclear pharmacist in paragraph (B)(1) of th...

... requirements. An authorized nuclear pharmacist who meets the requirements in rule 3701:1-58-20 or 3701:1-58-21 of the Administrative Code may provide the supervised work experience for paragraph (C)(1)(b)(vii) of this rule. Work experience must involve: (i) Ordering, receiving, and unpacking radioactive materials safely and performing the related radiation surveys; (ii) Performing qualit...

...dionuclides: (1) An authorized nuclear pharmacist; (2) A physician who is an authorized user and who meets the requirements specified in rule 3701:1-58-36 or 3701:1-58-40 of the Administrative Code; or (3) An individual under the supervision, as specified in rule 3701:1-58-14 of the Administrative Code, of the authorized nuclear pharmacist in paragraph (B)(1) of this rule or the physician who is an authorized user...

...uclides: (1) An authorized nuclear pharmacist; (2) A physician who is an authorized user and who meets the requirements specified in rule 3701:1-58-36 or 3701:1-58-40 of the Administrative Code; or (3) An individual under the supervision, as specified in rule 3701:1-58-14 of the Administrative Code, of the authorized nuclear pharmacist in paragraph (B)(1) of this rule or the physician who i...

...ner, including but not limited to a pharmacist, physician assistant, nurse aide, or supplier of durable medical equipment. (15) "Third-party payer" is as defined in section 3901.38 of the Revised Code. (D) Applicability and scope Except as otherwise specifically provided, the requirements of this rule apply to all issuers of policies or contracts of insurance, administrators of self-funded empl...

... and that are dispensed by a registered pharmacist from an enrolled pharmacy provider. (D) The bureau may require prior authorization of certain drugs or therapeutic classes of drugs, drugs above a certain cost threshold, drugs submitted outside a certain time frame from the date of injury or the last prescription submitted. or drugs being prescribed for a condition or in a manner not approved by...

... and that are dispensed by a registered pharmacist from an enrolled pharmacy provider. (D) The bureau may require prior authorization of certain drugs or therapeutic classes of drugs, drugs above a certain cost threshold, drugs submitted outside a certain time frame from the date of injury or the last prescription submitted. or drugs being prescribed for a condition or in a manner not approved by...

...njured workers. A list of physician and pharmacist providers, each holding a professional license in good standing, who have agreed to serve on the P&T committee and who would add credibility and diversity to the mission and goals of the committee shall be developed and maintained by the chief medical officer. Providers may also be nominated for inclusion on the list by provider associations and organizations includi...

...ured workers. A list of physician and pharmacist providers, each holding a professional license in good standing, who have expressed an interest in serving on the P&T committee and who would add credibility and diversity to the mission and goals of the committee shall be developed and maintained by the bureau. Providers may also be nominated for inclusion on the list by provider associations and organizat...

... and maintain a list of physician and pharmacist providers, each holding a professional license in good standing, who have expressed an interest in serving on the P&T committee and who would add credibility and diversity to the mission and goals of the committee . Providers may be nominated for inclusion on the list by provider associations and organizations including but not limited to: deans of Ohio's a...

...o an injured worker by a registered pharmacist from an enrolled outpatient pharmacy provider. (C) The formulary indicated in the appendix to this rule also contains specific reimbursement, prescribing or dispensing restrictions that have been placed on the use of listed drugs. The formulary will be reviewed and updated as necessary. The most current version will be electronically published by the...

...nd signed the prescription blank. A pharmacist or pharmacy intern who receives a telephone prescription may also write and sign that it is work related on the prescription. (F) If a claim in which the first fill of outpatient medication was reimbursed by the bureau pursuant to this rule is ultimately disallowed in a final administrative or judicial order, and if the employer is a state fund e...

...tion therapy management review by a pharmacist; and (d) Consultation with a specialist in addiction medicine or addiction psychiatry, if aberrant behaviors indicating medication misuse or substance use disorder are noted. (E) Prior to increasing the opioid dosage to a daily average of eighty MED or greater the dentist shall complete all of the following: (1) Enter into written pain treatmen...

...tion therapy management review by a pharmacist; and (d) Consultation with a specialist in addiction medicine or addiction psychiatry, if aberrant behaviors indicating medication misuse or substance use disorder are noted. (E) Prior to increasing the opioid dosage to a daily average of eighty MED or greater the dentist shall complete all of the following: (1) Enter into written pain treatmen...

...entification of the practitioner(s) and pharmacist(s) authorized to enter the agreement. They may include: (i) Individual names of the practitioner(s) and pharmacists; (ii) Practitioner or pharmacist practice groups; (iii) Identification based on institutional credentialing or privileging; or (iv) If multiple practitioners are entering the consult agreement, identification of the prima...

...ing into a consult agreement with a pharmacist. The agreement is subject to but not limited by the following standards: (1) The primary practitioner must ensure that the managing pharmacist has access to the patient's medical record, the medical record is accurate, and that while transferring the medical record, the primary practitioner ensures the confidentiality of the medical record. (2) ...

...dication therapy management review by a pharmacist; (iv) Consultation with a specialist in addiction medicine or addiction psychiatry, if aberrant behaviors indicating medication misuse or substance use disorder are noted; (c) The advanced practice registered nurse shall consider offering the patient a prescription for naloxone if the dosage exceeds fifty MED as discussed in paragraph (K)(4) of ...